All
How Love Helped Me Overcome my Cancer Diagnosis
Facing two life-threatening diagnoses, I overcame fear of self-injections by leaning on love, encouragement and determination to save my life.
FDA Approves UGN-102 For Some With Bladder Cancer
The FDA has granted approval to UGN-102 for use in patients with low-grade intermediate-risk non-muscle-invasive bladder cancer.
Don’t Miss Your Shot: A Letter to My Newly Diagnosed Self
Eminem’s lyric about having “one shot” stayed with me, and writing this letter to my newly diagnosed self, reminds me how that mindset saved my life.
What Patients With Genitourinary Cancers Need to Know After ASCO 2025
Dr. Joshua K. Sabari and Dr. Daniel V. Araujo provide expert insights into genitourinary cancer updates from ASCO 2025.
FDA Approves Brukinsa Tablet For Various Blood Cancers
FDA approves new Brukinsa tablet for five blood cancers, offering simpler dosing with the same safety and effectiveness as capsules.
A New Therapeutic Approach May Make Waves in Kidney Cancer Treatment
Dr. Michael Serzan provides expert takeaways on treatment updates for patients with early-stage kidney cancer following the 2025 ASCO Meeting.
Being a Cancer Survivor is a Gift I Never Take for Granted
Being a cancer survivor for nine and a half years has taught me to live in the moment, to make those moments count.
What Patients With Genitourinary Cancers Should Know After ASCO 2025
Dr. Joshua K. Sabari sat down with Dr. Daniel V. Araujo to discuss topline takeaways from the 2025 ASCO Meeting across the realm of genitourinary oncology
FDA Approves Ibtrozi for ROS1+ Advanced Non-Small Cell Lung Cancer
The U.S. FDA has approved treatment with Ibtrozi for patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer.
Connected by Shared Experiences and What Cancer Can’t Take Away
Two people connect by sharing their experiences about taking care of their spouses who died from cancer, and the realization that sparked something more.
Rusfertide Reduces Phlebotomy Need, Improves Quality of Life in Polycythemia Vera
Treatment with the investigational therapeutic rusfertide has proven to be a potential treatment option for patients with polycythemia vera.
FDA Grants Priority Review to Zepzelca Combo for Small Cell Lung Cancer
FDA granted priority review to Zepzelca plus Tecentriq for first-line maintenance in extensive-stage small cell lung cancer.
How to Prepare for Self-Advocacy After a Cancer Diagnosis
Patients can prepare for self-advocacy by bringing personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner.
Oncology Nurse Amanda Snyder Turns Personal Experience Into Advocacy
Amanda Snyder, a cancer survivor, became an oncology nurse to provide support she once lacked, now leading innovative therapies for patients.
Enhertu Combo May Offer Longer Control for HER2+ Breast Cancer
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
The LAURA Trial May Lead to a New Era of Care in Lung Cancer
Dr. Suresh Ramalingam discusses how Tagrisso has ushered in a new era of care for patients with advanced EGFR+ non-small cell lung cancer.
A Letter to My 2009 Self, Newly Diagnosed With Breast Cancer
I survived breast cancer and medical trauma, but the road was brutal. Fifteen years later, I’m alive, scarred and still searching for peace.
Understanding Breast Cancer Biomarkers Drives Patient Treatment Decisions
Dr. Mabel Mardones educates patients on breast cancer subtypes, as well as treatment options for those with ER-positive, HER2-negative disease.
FDA Grants Fast Track Status to PHST001 for Ovarian Cancer Treatment
The FDA grants fast track designation to PHST001, an antibody targeting CD24, for advanced platinum-resistant and platinum-sensitive ovarian cancer.
Expanding on a New Way to Manage Polycythemia Vera Without Iron Deficiency
The VERIFY trial explores rusfertide to manage polycythemia vera without causing iron deficiency symptoms, Dr. Aaron Gerds explained.
I Sometimes Forget to Celebrate Survivorship
Five years after my transplant for leukemia, I’m learning to focus on gratitude despite daily struggles, remembering that being alive is the greatest gift.
You Are Not Alone While Building a Support Team During Cancer Care
Michelle Kirschner discusses the how patients can foster a strong network of supporters from diagnosis through survivorship.
When Treatment Ends, Support Shouldn’t Stop in Cancer Care
Natalie Schnaitmann discusses the importance of self-advocacy and access to second opinions when symptoms are dismissed among young women with cancer.
The Gift of a Good Cancer Nurse
When it comes to living with cancer, your nurses make a difference.
Zilovertamab Vedotin Plus Chemo Combo Shows Responses in R/R DLBCL
The antibody-drug conjugate zilovertamab vedotin plus Rituxan and chemotherapy showed an objective response rate of 56.3% in relapsed/refractory DLBCL.
TERZO Trial Doses First Patient With Copiktra in Rare T-Cell Lymphoma
The first patient has been dosed in the phase 3 TERZO trial of Copiktra for relapsed or refractory nodal T-follicular helper cell lymphoma.
Protect Your Healing by Lowering Chemical Exposure After Cancer Diagnosis
It is important to understand why it is vital that patients and survivors of cancer take steps to reduce the body’s burden both before and after treatment.
Detailing the Potential Benefit of Intratumoral Therapies in Lung Cancer
Dr. Jared Weiss walks patients through the therapeutic potential viability of intratumoral therapies among those with lung cancer.
Targeted Chemo Improves Survival in Early-Stage Lung Cancer
Using a 14-gene test to guide chemotherapy significantly improved disease-free survival in patients with early nonsquamous lung cancer.
Utilizing AI in Prostate Cancer Care and Management
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
